Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;13(5):979-989.
doi: 10.1177/1932296819872107.

Digital Diabetes Congress 2019

Julia Han  1 , Fraya King  1 , David Klonoff  1   2 , Andjela Drincic  3 , Keesha Perkins Crosby  4 , Thomas Robinson  5 , Robert A Gabbay  6 , Leslie Oley  7 , David Ahn  8 , Bill Evans  9 , Patricia Salber  10 , Marisa Cruz  11 , Barry Ginsberg  12 , Saleh Adi  13 , David Armstrong  14   15 , David Kerr  16
Affiliations

Digital Diabetes Congress 2019

Julia Han et al. J Diabetes Sci Technol. 2019 Sep.

Abstract

New applications of digital health software and sensors for diabetes are rapidly becoming available. The link between healthcare, wearable or carryable devices, and the use of smartphones is increasingly being used by patients for timely information and by healthcare professionals to deliver information and personalized advice and to encourage healthy behavior. To assemble stakeholders from academia, industry, and government, Diabetes Technology Society and Sansum Diabetes Research Institute hosted the 3rd Annual Digital Diabetes Congress on May 14-15, 2019 in San Francisco. Physicians, entrepreneurs, attorneys, psychologists, and other leaders in the diabetes technology field came together to discuss current and future trends and applications of digital tools in diabetes. The meeting focused on eight topics: 1) User Interface/User Experience (UI/UX) for Digital Health, 2) clinical aspects, 3) marketing, 4) investment, 5) regulation, 6) who owns the data, 7) engagement, and 8) the future of digital health. This meeting report contains summaries of the meeting's eight plenary sessions and eight panel discussions, which were all focused on an important aspect of the development, use, and regulation of diabetes digital tools.

Keywords: data; diabetes; digital health; privacy; risk.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Julia Han has nothing to disclose. Fraya King is a consultant to Abbott Diabetes Care. David Klonoff is a consultant to Abbott, Ascensia, EOFlow, Know, Lifecare, Merck, Novo, Roche, and Voluntis. Andjela Drincic has nothing to disclose. Keesha Perkins Crosby has nothing to disclose. Thomas Robinson serves on Advisory Boards for WW International, Inc. Robert Gabbay is a consultant to Onduo, Lark, and Health Reveal. Leslie Oley has equity in Evidation Health. David Ahn has research support, has acted as a consultant, or served on the scientific advisory board for Senseonics, Mannkind, Ascensia, and Companion Medical. Bill Evans has nothing to disclose. Patricia Salber has nothing to disclose. Marisa Cruz has nothing to disclose. Barry Ginsberg is consulting medical director for Facet Technologies and SFC Fluidics. Saleh Adi is consultant, speaker bureau, shareholder for Dexcom and a shareholder for Tandem. David Armstrong has nothing to disclose. David Kerr is an advisor to Glooko, Vicentra and hi.health. He has received payments for participation in advisory boards focusing on digital health for Ascensia, Novonordisk and Sanofi and is in receipt of research funding from Lilly.

Publication types

LinkOut - more resources